A Prediction Rule for Estimating the Risk of Bacteremia in Patients with Community-Acquired Pneumonia

被引:77
作者
Falguera, Miquel [1 ]
Trujillano, Javier [2 ]
Caro, Silvia [1 ]
Menendez, Rosario [5 ]
Carratala, Jordi [6 ]
Ruiz-Gonzalez, Agustin [1 ]
Vila, Manuel [3 ]
Garcia, Merce [4 ]
Manuel Porcel, Jose [1 ]
Torres, Antoni [7 ]
机构
[1] Univ Lleida, Hosp Univ Arnau de Vilanova, Serv Internal Med, Inst Recerca Biomed Lleida, Lleida, Spain
[2] Univ Lleida, Hosp Univ Arnau de Vilanova, Serv Crit Care, Inst Recerca Biomed Lleida, Lleida, Spain
[3] Univ Lleida, Hosp Univ Arnau de Vilanova, Serv Pneumol, Inst Recerca Biomed Lleida, Lleida, Spain
[4] Univ Lleida, Hosp Univ Arnau de Vilanova, Microbiol Serv, Inst Recerca Biomed Lleida, Lleida, Spain
[5] Hosp Univ La Fe, Serv Pneumol, Valencia, Spain
[6] Univ Barcelona, Infect Dis Serv, Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge, E-08007 Barcelona, Spain
[7] Univ Barcelona, Dept Pneumol, Clin Inst Thorax, Hosp Clin Barcelona,Inst Invest Biomed August Pi, E-08007 Barcelona, Spain
关键词
BLOOD CULTURES; MANAGEMENT; IDENTIFY; ETIOLOGY;
D O I
10.1086/600291
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. We endeavored to construct a simple score based entirely on epidemiological and clinical variables that would stratify patients who require hospital admission because of community-acquired pneumonia into groups with a low or high risk of developing bacteremia. Methods. Derivation and internal validation cohorts were obtained by retrospective analysis of a database that included 3116 consecutive patients with community-acquired pneumonia from 2 university hospitals. Potential predictive factors were determined by means of a multivariate logistic regression equation applied to a cohort consisting of 60% of the patients. Points were assigned to significant parameters to generate the score. It was then internally validated with the remaining 40% of patients and was externally validated using an independent multicenter cohort of 1369 patients. Results. The overall rates of bacteremia were 12%-16% in the cohorts. The clinical probability estimate of developing bacteremia was based on 6 variables: liver disease, pleuritic pain, tachycardia, tachypnea, systolic hypotension, and absence of prior antibiotic treatment. For the score, 1 point was assigned to each predictive factor. In the derivation cohort, a cutoff score of 2 best identified the risk of bacteremia. In the validation cohorts, rates of bacteremia were <8% for patients with a score <= 1 ( 43%-49% of patients), whereas blood culture results were positive in 14%-63% of cases for patients with a score >= 2. Conclusions. This clinical score, based on readily available and objective variables, provides a useful tool to predict bacteremia. The score has been internally and externally validated and may be useful to guide diagnostic decisions for community-acquired pneumonia.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 24 条
[1]   COMMUNITY-ACQUIRED PNEUMONIA [J].
BARTLETT, JG ;
MUNDY, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1618-1624
[2]   Predicting bacteremia in patients with sepsis syndrome [J].
Bates, DW ;
Sands, K ;
Miller, E ;
Lanken, PN ;
Hibberd, PL ;
Graman, PS ;
Schwartz, JS ;
Kahn, K ;
Snydman, DR ;
Parsonnet, J ;
Moore, R ;
Black, E ;
Johnson, BL ;
Jha, A ;
Platt, R .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (06) :1538-1551
[3]   The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia - A prospective observational study [J].
Campbell, SG ;
Marrie, TJ ;
Anstey, R ;
Dickinson, G ;
Ackroyd-Stolarz, S .
CHEST, 2003, 123 (04) :1142-1150
[4]   EFFICACY, SAFETY, AND THERAPEUTIC RELEVANCE OF TRANSTHORACIC ASPIRATION WITH ULTRATHIN NEEDLE IN NONVENTILATED NOSOCOMIAL PNEUMONIA [J].
DORCA, J ;
MANRESA, F ;
ESTEBAN, L ;
BARREIRO, B ;
PRATS, E ;
ARIZA, J ;
VERDAGUER, R ;
GUDIOL, F .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (05) :1491-1496
[5]   Applying sputum as a diagnostic tool in pneumonia -: Limited yield, minimal impact on treatment decisions [J].
Ewig, S ;
Schlochtermeier, M ;
Göke, N ;
Niederman, MS .
CHEST, 2002, 121 (05) :1486-1492
[6]   Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus [J].
Falguera, K ;
Pifarre, R ;
Martin, A ;
Sheikh, A ;
Moreno, A .
CHEST, 2005, 128 (05) :3233-3239
[7]   Community-acquired pneumonia as the initial manifestation of serious underlying diseases [J].
Falguera, M ;
Martín, M ;
Ruiz-González, A ;
Pifarré, R ;
García, M .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (04) :378-383
[8]  
Fernández-Sabé N, 2003, MEDICINE, V82, P159, DOI 10.1097/00005792-200305000-00002
[9]   A prediction rule to identify low-risk patients with community-acquired pneumonia [J].
Fine, MJ ;
Auble, TE ;
Yealy, DM ;
Hanusa, BH ;
Weissfeld, LA ;
Singer, DE ;
Coley, CM ;
Marrie, TJ ;
Kapoor, WN .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (04) :243-250
[10]   Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia [J].
Houck, PM ;
Bratzler, DW ;
Nsa, W ;
Ma, A ;
Bartlett, JG .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (06) :637-644